{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T07:42:28Z","timestamp":1770104548850,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["GAP-3183"],"award-info":[{"award-number":["GAP-3183"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.bioorg.2026.109557","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T16:45:53Z","timestamp":1769186753000},"page":"109557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elucidating the potential of novel class biphenyl-phenyl acetate, IDD-AN-A1, an inhibitor targeting Isocitrate Lyase in Mycobacterium tuberculosis: A target to lead approach"],"prefix":"10.1016","volume":"170","author":[{"given":"Anjali","family":"Negi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Summaya","family":"Perveen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harpreet","family":"Kour","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanghapal D.","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rashmi","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109557_bb0005","series-title":"Mycobacterium tuberculosis Pathogenesis, Infection Prevention and Treatment, Pathogens","first-page":"385","volume":"9","author":"Miggiano","year":"2020"},{"key":"10.1016\/j.bioorg.2026.109557_bb0010","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.bioorg.2026.109557_bb0015","author":"Borah","year":"2021","journal-title":"Metabolic flux partitioning between the TCA cycle and glyoxylate shunt combined with a reversible methyl citrate cycle provide nutritional flexibility for Mycobacterium tuberculosis"},{"key":"10.1016\/j.bioorg.2026.109557_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116058","article-title":"The significance of persisters in tuberculosis drug discovery: exploring the potential of targeting the glyoxylate shunt pathway","volume":"265","author":"Negi","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109557_bb0025","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/mmi.14362","article-title":"Mycobacterium tuberculosis requires glyoxylate shunt and reverse methylcitrate cycle for lactate and pyruvate metabolism","volume":"112","author":"Serafini","year":"2019","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2026.109557_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12614-7","article-title":"Acetyl-CoA-mediated activation of Mycobacterium tuberculosis isocitrate lyase 2","volume":"10","author":"Bhusal","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2026.109557_bb0035","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nm1252","article-title":"Mycobacterium tuberculosis isocitrate lyases 1 and 2 are jointly required for in vivo growth and virulence","volume":"11","author":"Mu\u00f1oz-El\u00edas","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.109557_bb0040","doi-asserted-by":"crossref","first-page":"3166","DOI":"10.1099\/mic.0.030858-0","article-title":"Major roles of isocitrate lyase and malate synthase in bacterial and fungal pathogenesis","volume":"155","author":"Dunn","year":"2009","journal-title":"Microbiology"},{"key":"10.1016\/j.bioorg.2026.109557_bb0045","doi-asserted-by":"crossref","first-page":"4420","DOI":"10.1021\/bi00261a035","article-title":"Inhibition of isocitrate lyase by 3-nitropropionate, a reaction-intermediate analog","volume":"21","author":"Schloss","year":"1982","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2026.109557_bb0050","series-title":"3-Nitropropionic Acid Exacerbates n-Methyl-Aspartate Toxicity in Striatal Culture by Multiple Mechanisms","author":"Greene","year":"1998"},{"key":"10.1016\/j.bioorg.2026.109557_bb0055","doi-asserted-by":"crossref","first-page":"986","DOI":"10.2741\/2119","article-title":"Mitochondrial toxins and neurodegenerative diseases","volume":"12","author":"Ayala","year":"2007","journal-title":"Front. Biosci."},{"key":"10.1016\/j.bioorg.2026.109557_bb0060","doi-asserted-by":"crossref","first-page":"114906","DOI":"10.1016\/j.bcp.2021.114906","article-title":"Screening approaches and therapeutic targets: the two driving wheels of tuberculosis drug discovery","volume":"197","author":"Perveen","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109557_bb0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11224-020-01612-x","article-title":"Substituent effects of nitro group in cyclic compounds","volume":"32","author":"Jezuita","year":"2021","journal-title":"Struct. Chem."},{"key":"10.1016\/j.bioorg.2026.109557_bb0070","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1021\/acs.jmedchem.8b00147","article-title":"Nitro-group-containing drugs","volume":"62","author":"Nepali","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109557_bb0075","doi-asserted-by":"crossref","first-page":"6842","DOI":"10.1016\/j.bmcl.2013.10.010","article-title":"Anti-tubercular agents. Part 8: synthesis, antibacterial and antitubercular activity of 5-nitrofuran based 1,2,3-triazoles","volume":"23","author":"Kamal","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109557_bb0080","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.bmcl.2014.05.018","article-title":"Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular activity","volume":"24","author":"Rane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109557_bb0085","doi-asserted-by":"crossref","first-page":"5149","DOI":"10.1016\/j.bmcl.2011.07.062","article-title":"Synthesis of various 3-nitropropionamides as Mycobacterium tuberculosis isocitrate lyase inhibitor","volume":"21","author":"Sriram","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109557_bb0090","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1021\/acsinfecdis.3c00463","article-title":"Identification of chemical scaffolds targeting drug-resistant and latent Mycobacterium tuberculosis through high-throughput whole-cell screening","volume":"10","author":"Perveen","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.bioorg.2026.109557_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2025.112537","article-title":"Early preclinical development of Mycobacterium tuberculosis amino acid biosynthesis pathway inhibitor DRILS-1398 as a potential anti-TB drug","volume":"28","author":"Biswas","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.bioorg.2026.109557_bb0100","first-page":"2014","article-title":"Assessment of nonsteroidal anti-inflammatory drug-induced cardiotoxicity","volume":"10","author":"Kumar","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109557_bb0105","doi-asserted-by":"crossref","DOI":"10.1093\/ehjcvp\/pvw041","article-title":"Non-steroidal anti-inflammatory drug use is associated with increased risk of out-of-hospital cardiac arrest: a nationwide case\u2013time\u2013control study","author":"Sondergaard","year":"2016","journal-title":"Eur. Heart J. Cardiovas. Pharmacother."},{"key":"10.1016\/j.bioorg.2026.109557_bb0110","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.i4857","article-title":"Non-steroidal anti-inflammatory drugs and risk of heart failure in four European countries: nested case-control study","author":"Arf\u00e8","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.bioorg.2026.109557_bb0115","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1007\/s40265-019-01207-9","article-title":"Pretomanid: first approval","volume":"79","author":"Keam","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.bioorg.2026.109557_bb0120","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.tube.2018.04.008","article-title":"Delamanid: from discovery to its use for pulmonary multidrug-resistant tuberculosis (MDR-TB)","volume":"111","author":"Liu","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.bioorg.2026.109557_bb0125","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2013.09.039","article-title":"Synthesis and evaluation of novel 4-nitropyrrole-based 1,3,4-oxadiazole derivatives as antimicrobial and anti-tubercular agents","volume":"70","author":"Rane","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109557_bb0130","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3390\/metabo11020088","article-title":"Metabolic versatility of Mycobacterium tuberculosis during infection and dormancy","volume":"11","author":"Chang","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.bioorg.2026.109557_bb0135","doi-asserted-by":"crossref","first-page":"18925","DOI":"10.1038\/s41598-020-75799-8","article-title":"Demystifying the catalytic pathway of Mycobacterium tuberculosis isocitrate lyase","volume":"10","author":"Ibeji","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109557_bb0140","doi-asserted-by":"crossref","first-page":"376","DOI":"10.7150\/ijbs.7.376","article-title":"Identification of Mannich Base as a novel inhibitor of Mycobacterium tuberculosis Isocitrate by high-throughput screening","volume":"7","author":"Ji","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bioorg.2026.109557_bb0145","doi-asserted-by":"crossref","DOI":"10.1021\/acs.jmedchem.4c02568","article-title":"Keeping up with the q's: mechanistic insights and validation of Quinoline and Quinazoline scaffolds as potent drugs against tuberculosis","author":"Negi","year":"2025","journal-title":"J. Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826000933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T21:13:20Z","timestamp":1770066800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826000933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":29,"alternative-id":["S0045206826000933"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109557","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the potential of novel class biphenyl-phenyl acetate, IDD-AN-A1, an inhibitor targeting Isocitrate Lyase in Mycobacterium tuberculosis: A target to lead approach","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109557"}}